We are pleased to announce funding was awarded by the NIMH for “Genetics at an Extreme: An Efficient Genomic Study of Individuals with Clinically Severe Major Depression Receiving ECT,” for a total of more than $5 million over a five-year period. Congratulations to co-principal investigators Peter Zandi, PhD, and Patrick Sullivan, MD, who, together with Richard Weiner, MD, Daniel Maixner, MD, and Irving Reti, MD, will lead a team of investigators from around the world on this groundbreaking study of the genetics of ECT and depression.